Study suggests drug could help with breast cancer survivors' hot flashes



The drug is oxybutynin, or Ditropan XL, long used to treat urinary incontinence.

The study found that women taking the medicine had an average of five fewer hot flashes a week, compared with three fewer among women taking a placebo.

"Oxybutynin is an option that can control these symptoms and improve quality of life," said lead researcher Dr. Roberto Leon-Ferre, an assistant professor of oncology at the Mayo Clinic in Rochester, Minn.

CONTINUE READING ON www.upi.com

                   

Related News